News

CoreValve, high risk study, TAVR, Medtronic, ACC

Medtronic plc unveiled new two-year data from the CoreValve U.S. Pivotal High Risk Study, which demonstrated superior two-year survival benefits from transcatheter aortic valve replacement (TAVR)...

Edwards, Sapien, PARTNER trial, five-year outcomes, ACC

Five-year data suggest that the Sapien transcatheter heart valve (Edwards Lifesciences) is a feasible option for patients with severe aortic stenosis deemed to be at high risk for open-heart...

Boston Scientific, Watchman LAA device, FDA approval

Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for the Watchman left atrial appendage closure device. The Watchman device offers a new stroke risk reduction...

AtriCure Inc. announced the first two patients in the Dual Epicardial and Endocardial Procedure (DEEP) clinical study have been enrolled and treated at PinnacleHealth CardioVascular...

congenital heart, adults, early detection, Penn State Hershey, CHD

At one time, many children born with congenital heart disease (CHD) suffered from issues that carried fatal prognoses. Thanks to technological advancements in the past 30 to 40 years, Elizabeth...

TAVR, TAVI, acc, ACC.15, corevalve

Key data from many transcatheter aortic valve replacement (TAVR) clinical trials will be presented as late-breakers at the American College of Cardiology (ACC) Scientific Session this weekend,...

STS, CHSD, congenital heart, trial, surgery, database, pediatric

The Society of Thoracic Surgeons (STS) has released the first publicly accessible national report of surgical outcomes from its Congenital Heart Surgery Database (CHSD), a component of the STS...

TAVR, study, one-year outcomes, heart valve repair, JAMA, Mayo Clinic

In an analysis of outcomes of about 12,000 patients who underwent transcatheter aortic valve replacement (TAVR), death rate after one year was nearly one in four, according to a study in the March...

Four-month-old Jackson Lane has a large scar that looks like a giant zipper down the center of his chest, the result of undergoing a lifesaving surgical procedure at just five days old to repair...

TMVR, Europe, heart valve repair, GlobalData

In light of a recent American Heart Association report stating that U.S. mitral valve regurgitation prevalence was 1.7 percent in 2014, a significant opportunity exists for development of an...

Pie Medical Imaging, CAAS A-Valve, qRA, angiography, heart valve repair

Pie Medical Imaging BV announced that it received 510(k) clearance from the U.S. Food and Drug Administration for its CAAS A-Valve product including the quantitative Regurgitation Analysis (qRA)...

TAVR, Henry Ford Hospital, O'Neill, Greenbaum

Transcatheter aortic valve replacement (TAVR) is not only a breakthough minimally invasive medical therapy, but offers a new business opportunity for hospitals that begin a program. The technology...

University of Michigan, heart defect, baby, screening test

Thanks to a two-minute newborn screening test designed to help detect heart defects, a Michigan couple was made aware of their newborn daughter’s unexpected heart defect. The test is now a...

Here are my predictions for technologies to watch in the coming year that have the potential to fundamentally change the practice of cardiology:

Corevalve, valve sizes

Medtronic announced CE (Conformité Européene) mark for the 26 and 29mm sizes of the CoreValve Evolut R System, a next-generation self-expanding valve for transcatheter aortic...

Heart failure, MitraClip, International Symposium on Endovascular Therapy

A minimally invasive procedure to repair severe mitral valve regurgitation by clipping together the valve’s leaflets can improve function and quality of life and reduce the risk of hospitalization...

Stem Cell Therapy, Congenital heart, clinical trial/study

Researchers at Okayama University and Okayama University Hospital show that children suffering from a condition known as hypoplastic left heart syndrome experienced some improvement in cardiac...

Clinical trial/Study, Heart Valve Repair, CoreValve System

Medtronic revealed new one-year clinical data showing that transcatheter aortic valve replacement (TAVR) with the self-expanding CoreValve System offers advantages in survival and safety compared...

Neovasc Inc. has commenced a public offering in the United States of 8 million shares of the company to raise money for upcoming U.S. clinical trials and development of its transcatheter mitral...

Balloon catheters, Heart Valve repair, Cath Lab, Hybrid OR

Maquet Medical Systems USA announced an agreement to serve as the exclusive U.S. distributor of InterValve Inc.'s V8 Aortic Valvuloplasty Balloon Catheter.